Archivio Istituzionale della RicercaOnly 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison / Marra, G., Soeterik, T., Oreggia, D., Tourinho-Barbosa, R., Moschini, M., Stabile, A., Filippini, C., van Melick, H.H., van den Bergh, R.C., Gontero, P., Pasquali, C., Macek, P., Cathala, N., Sanchez-Salas, R., Cathelineau, X.. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1938-0682. - 20:6(2022), pp. 592-604. [10.1016/j.clgc.2022.06.009]
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison
Marra, Giancarlo;Gontero, Paolo;
2022
Abstract
Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.
| File | Dimensione | Formato | |
|---|---|---|---|
|
89 - Clin Gen Ca HIFU def.pdf
accesso riservato
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
1.13 MB
Formato
Adobe PDF
|
1.13 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2983456